BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31562527)

  • 41. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration.
    Whitwell JL; Jack CR; Senjem ML; Parisi JE; Boeve BF; Knopman DS; Dickson DW; Petersen RC; Josephs KA
    Neurodegener Dis; 2009; 6(3):106-17. PubMed ID: 19299900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.
    Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ
    Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration.
    Bridel C; van Gils JHM; Miedema SSM; Hoozemans JJM; Pijnenburg YAL; Smit AB; Rozemuller AJM; Abeln S; Teunissen CE
    Alzheimers Res Ther; 2023 Mar; 15(1):59. PubMed ID: 36949537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
    Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
    Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.
    Phillips JS; Robinson JL; Cousins KAQ; Wolk DA; Lee EB; McMillan CT; Trojanowski JQ; Grossman M; Irwin DJ
    J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38050082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP-43 inclusions and ageing-related tau astrogliopathy in a family with a GBE1 mutation.
    Uemura MT; Suh ER; Robinson JL; Brunden KR; Grossman M; Irwin DJ; Lee VM; Trojanowski JQ; Lee EB; Van Deerlin VM
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12865. PubMed ID: 36456471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between CSF tau biomarkers and structural brain MRI measures in frontotemporal lobar degeneration.
    Fenu G; Oppo V; Serra G; Lorefice L; Di Sfefano F; Deagostini D; Mancosu C; Fadda E; Melis C; Siotto P; Cocco E; Melis M; Cossu G
    J Neurol Sci; 2022 Nov; 442():120415. PubMed ID: 36115219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
    Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Old age genetically confirmed frontotemporal lobar degeneration with TDP-43 has limbic predominant TDP-43 deposition.
    Buciuc M; Whitwell JL; Baker MC; Rademakers R; Dickson DW; Josephs KA
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1050-1059. PubMed ID: 33969528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
    Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
    J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
    Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
    Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
    Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology.
    Wisse LEM; de Flores R; Xie L; Das SR; McMillan CT; Trojanowski JQ; Grossman M; Lee EB; Irwin D; Yushkevich PA; Wolk DA;
    Alzheimers Res Ther; 2021 May; 13(1):100. PubMed ID: 33990226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
    Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct Patterns of Hippocampal Pathology in Alzheimer's Disease with Transactive Response DNA-binding Protein 43.
    Minogue G; Kawles A; Zouridakis A; Keszycki R; Macomber A; Lubbat V; Gill N; Mao Q; Flanagan ME; Zhang H; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Ann Neurol; 2023 Dec; 94(6):1036-1047. PubMed ID: 37592884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
    Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Josephs KA
    J Mol Neurosci; 2011 Nov; 45(3):372-8. PubMed ID: 21556732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.